Prognostic Value of Pulse Oximetry Differences
Prognostic Significance of Multi-site Pulse Oximetry Differences in Dyspneic Emergency Department Patients
2 other identifiers
observational
400
1 country
1
Brief Summary
This prospective observational study aims to evaluate whether the difference between finger, earlobe and forehead SpO₂ (ΔSpO₂) measured at emergency department (ED) presentation is associated with clinical outcomes in adult patients presenting with dyspnea. We will compare ΔSpO₂ between patients with poor outcomes (death or intensive care unit \[ICU\] admission) and those with favorable outcomes. Secondary objectives include assessing the prognostic value of ΔSpO₂ for mortality, ICU admission, and lactate, and comparing its predictive performance with established early warning scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 29, 2026
CompletedFirst Submitted
Initial submission to the registry
May 30, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
September 17, 2026
September 1, 2026
10 months
May 30, 2026
September 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
In-hospital mortality or ICU admission
In-hospital mortality or ICU admission of index visit
From the index emergency department visit through hospital discharge, assessed up to 6 months.
Study Arms (1)
Dyspnea cohort
Patients visiting emergency department with dyspnea who are categorized to KTAS 1-3
Eligibility Criteria
We will enroll patients who meet the enrollment criteria who visit an emergency department of a tertiary teaching hospital located in Seoul, South Korea.
You may qualify if:
- Adult patients aged 19 years or older presenting to the emergency department with dyspnea, classified as KTAS level 1-3
You may not qualify if:
- Patients in whom SpO₂ measurements were not obtained simultaneously
- Patients in whom arterial blood gas analysis was not ordered at initial evaluation
- Pregnant patients
- Patients with facial trauma or hand trauma
- Patients with amputation, injury, or burns at the measurement sites
- Patients wearing nail polish
- Patients with dyshemoglobinemia
- Non-Korean nationality
- Patients who did not provide consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yonsei University Severance Hospital
Seoul, Seoul, 03722, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical assistant professor
Study Record Dates
First Submitted
May 30, 2026
First Posted
September 17, 2026
Study Start
May 29, 2026
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
September 17, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to concerns regarding patient privacy and personal information protection.